Bobrov V A, Frolov A I, Mitchenko E I, Galichansky I V
N. D. Strazhesko Institute of Cardiology, Kiev, Ukraine.
Rev Port Cardiol. 1994 Mar;13(3):221-5.
In the aim of determining an electrophysiologic effect of disopyramide and metoprolol at alone therapy and in combination in patients with supraventricular tachycardia on the background of Wolff-Parkinson-White syndrome 23 persons were examined. All patients were subjected to an intracardiac electrophysiological testing; in its process metoprolol in the dosage of 0.2 mg/kg of body weight, disopyramide in the dosage of 2 mg/kg per body weight both separately and in combination were controlled. It was identified that metoprolol and disopyramide are an effective antiarrhythmic preparates applied for arresting and prevention of reciprocating orthodromic tachycardias in patients with Wolff-Parkinson-White syndrome.
为了确定在 Wolff-Parkinson-White 综合征背景下,丙吡胺和美托洛尔单独治疗及联合治疗对室上性心动过速患者的电生理效应,对 23 名患者进行了检查。所有患者均接受了心内电生理测试;在此过程中,分别及联合控制了体重 0.2mg/kg 的美托洛尔、体重 2mg/kg 的丙吡胺。结果发现,美托洛尔和丙吡胺是有效的抗心律失常制剂,可用于终止和预防 Wolff-Parkinson-White 综合征患者的折返性正向心动过速。